John J. Brewington

Cincinnati Children's Hospital Medical Center — United States

Medicine · Health Sciences

16h-index685citations60works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(32), Neonatal Respiratory Health Research(23), Tracheal and airway disorders(22), Neutrophil, Myeloperoxidase and Oxidative Mechanisms(5), Inhalation and Respiratory Drug Delivery(4)

Publications60 total

710 Near-road air pollution inhibits long-term modulator effectiveness
Journal of Cystic Fibrosis·2025
88 Neutrophil extracellular traps increase human bronchial epithelial iron release and promote Pseudomonas aeruginosa growth
Journal of Cystic Fibrosis·2025
659 Lung function decline persists among healthy children with CF taking elexacaftor/tezacaftor/ivacaftor
Journal of Cystic Fibrosis·2025
TGF-β induces excessive pulmonary IL-6 secretion in cystic fibrosis via PI3K
American Journal of Physiology-Lung Cellular and Molecular Physiology·2025Open Access
Aligning Expectations With Outcomes: A Prospective Study of Pediatric Bronchoscopy in the ICU Setting
American Journal of Respiratory and Critical Care Medicine·2025
Use of Bronchoscopic Cryotherapy for Recanalization and Cryoextraction in Pediatric Population: A Five-Year Single Center Experience
American Journal of Respiratory and Critical Care Medicine·2025
Spike and Slab Regression for Nonstationary Gaussian Linear Mixed Effects Modeling of Rapid Disease Progression
Environmetrics·2024· 3 citedOpen Access
198 Neutrophil extracellular traps increase Pseudomonal density in human bronchial epithelia
Journal of Cystic Fibrosis·2024
327 Comparison of human nasal and fisher rat thyroid cell-based theratyping results
Journal of Cystic Fibrosis·2024
HYPER-LOCALIZATION AND PREDICTIVE MODELING OF RAPID CYSTIC FIBROSIS DISEASE PROGRESSION
Annals of Epidemiology·2024
Evaluation of elexacaftor–tezacaftor–ivacaftor treatment in individuals with cystic fibrosis and CFTRN1303K in the USA: a prospective, multicentre, open-label, single-arm trial
The Lancet Respiratory Medicine·2024· 18 cited
Quantifying abnormal alveolar microstructure in cystic fibrosis lung disease via hyperpolarized 129Xe diffusion MRI
Journal of Cystic Fibrosis·2024· 7 citedOpen Access
Elexacaftor-Tezacaftor-Ivacaftor Improves Clinical Outcomes in Individuals with CF Encoding N1303K CFTR
SSRN Electronic Journal·2024· 3 citedOpen Access
A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms
Pediatric Pulmonology·2023· 3 citedOpen Access
Upper Airway Disease in Cystic Fibrosis
2023
618 Environmental exposures and spatiotemporal effects that characterize rapid lung function decline in a Midwest U.S. cystic fibrosis cohort
Journal of Cystic Fibrosis·2023Open Access
98 Neutrophil extracellular traps disrupt bronchial epithelial junctional integrity and promote infection
Journal of Cystic Fibrosis·2023Open Access
168 Impact of TGF-β exposure on IL-6 secretion in cystic fibrosis airway epithelia
Journal of Cystic Fibrosis·2023· 1 citedOpen Access
A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms
2023
Flexible Bronchoscopy in Critically Ill Children and Impact of a High-risk Bronchoscopy Team (HRBT) in a High-volume Center
2023
page 1 of 3Next →

Frequent Co-authors

John P. Clancy(19), Alicia J. Ostmann(8), Elizabeth L. Kramer(8), M. Imbrogno(6), Francis J. LaRosa(5), Lauren Strecker(5), Dan Benscoter(5), Kristin Hudock(5), Bruce C. Trapnell(5), Rhonda D. Szczesniak(5), A. Ostmann(5), Erin T. Filbrandt(4), Jessica Moncivaiz(4), Assem Ziady(4), George M. Solomon(4), Kavisha Arora(4), Anjaparavanda P. Naren(4), Emrah Gecili(4), Cole Brokamp(4), Margaret S. Collins(3)